Login

Unlocking Your HSA's Potential for Retirement | David Seufer, CFA of Gravitas Wealth Planning 00:10:00

Share On Facebook Share On Twitter

David Seufer is the CFA of Gravitas Wealth Planning

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Milton Pilão Discusses Brazil's Sustainable Methane Capture and Waste Management Initiatives | Milton Pilão Júnior, CEO , Orizon Valorizacao de Residuos SA.
00:10:00
Tier One Silver: Advancing Peru's Premier Silver Exploration Projects
00:10:00
Jonathan Nelson: Building Providence Equity's $45 Billion Legacy in Media and Telecom | Jonathan Nelson, CEO, Providence Equity Partners.
00:10:00
Navigating the Best Offshore Havens: Insights on Corporate & Banking Choices | John Millar - Offshore Strategy Expert, GlobalBanks
00:10:00
At bpost Group, the collective dedication of over 34,000 employees worldwide drives daily efforts to foster growth and excellence in service provision.|Chris Peeters is CEO of bpostgroup
00:10:00
Geoscience INTEGRATOR: Your Comprehensive Mineral Exploration Data Solution | John McGaughey ,President of Mira Geoscience Ltd.
00:10:00
We deliver for investors by building businesses that power tomorrows economy|Dwight Scott,Chairman,GSO Capital Partners LP
00:10:00
Azuma Resources: Transformational Discoveries and Ongoing Drilling at Wa Project in Ghana
00:10:00
Donald Rumsfeld on Leadership, Defense, and Known and Unknown Challenges
00:10:00
Nevada Copper's Path to Production: Insights from President and CEO Matthew Kelly at the One-to-One Mining Investment Conference in New York
00:10:00
Unveiling Potential: Oz Golden's Pursuit of Gold at Kittanning
00:00:00
Ian Walters, CEO, SalvaRx Group Plc

© 2017 - Neuhu+